Nail-Patella Syndrome

Nail-patella syndrome (NPS) - also called hereditary onycho-osteodysplasia or Fong disease - is a rare connective-tissue and developmental disorder.

• Genetics: Mutations in LMX1B on chromosome 9q34, a LIM-homeodomain transcription factor.
• Inheritance: Autosomal dominant with high penetrance but very variable expression, even within one family.
• Prevalence: Approximately 1 in 50,000.
• Defining concept: A single transcription factor defect produces both dorsoventral limb patterning errors (nails, patella, elbow) and a glomerular basement membrane defect (nephropathy).

Why one gene causes such varied features

LMX1B is a transcription factor required for normal dorsoventral patterning of the limb during development and for normal podocyte and glomerular basement membrane formation. Loss of one functional copy (haploinsufficiency) disrupts both pathways.

Limb / skeletal effects

• Failure of normal dorsalisation leads to dorsal limb structures being underdeveloped: nails (dorsal-most ectodermal structure) and the patella (a dorsal sesamoid).
• The trochlear groove forms abnormally (shallow/dysplastic), so even a present patella is unstable.

Knee instability mechanism

• Absent or small patella, shallow dysplastic trochlea, and abnormal extensor mechanism alignment combine to drive lateral subluxation/dislocation.
• A distinctive feature reported in NPS is a synovial/fibrous band that can physically prevent the patella from engaging the groove - a pathology unlike ordinary patellofemoral instability.

Renal effects

• LMX1B controls expression of podocyte genes and type IV collagen chains; its loss produces a defective glomerular basement membrane with characteristic fibrillar collagen (type III) deposits and electron-lucent areas on electron microscopy, manifesting as proteinuria.

History:

• Family history (autosomal dominant) - examine relatives' nails.
• Recurrent knee giving way, dislocation, anterior knee pain.
• Any known proteinuria, hypertension, renal disease.
• Visual symptoms / glaucoma history.

Physical Exam:

1. Nails: Inspect all fingernails - hypoplasia, ridging, triangular lunulae (thumb worst).
2. Knees: Palpate for patella (may be impalpable), patellar tracking, apprehension, J-sign, effusion, range of motion.
3. Elbows: Extension and supination loss, palpable dislocated radial head, cubitus valgus, pterygia.
4. Pelvis: Iliac horns are not usually palpable - found on imaging.
5. General: Blood pressure, urine dipstick where possible.

Radiographs:

• AP pelvis: Look for iliac horns (pathognomonic).
• Knee (AP, lateral, skyline): Absent/hypoplastic patella, lateral subluxation, trochlear dysplasia.
• Elbow: Radial head dislocation, hypoplastic capitellum.

Cross-sectional imaging:

• MRI knee: Cartilaginous patella anlage, trochlear morphology, extensor mechanism, and any synovial band before realignment surgery.

Renal / systemic:

• Urinalysis for proteinuria and haematuria; quantify with protein:creatinine ratio.
• Blood pressure, renal function; renal biopsy only if significant nephropathy needs characterisation.
• Ophthalmology review for glaucoma.

Genetics:

• LMX1B sequencing confirms the diagnosis and aids family counselling.

Knee / Patellar Complications

Systemic Complications

Perioperative Considerations

• Renal status: Check renal function and proteinuria before any elective surgery and adjust nephrotoxic drugs/NSAIDs.
• Family screening: Other affected relatives may have undiagnosed nephropathy.
• Realistic expectations: Knee surgery improves pain more reliably than it abolishes instability.

After Patellar Realignment

• Immobilisation: Brace in extension initially, then progressive flexion as per construct.
• Rehabilitation: Early quadriceps activation, VMO-focused strengthening, gradual return to activity over 3-6 months.
• Monitoring: Watch for redislocation and effusion; reassess tracking.

Long-term Surveillance

Special Considerations

• Genetic counselling: Reinforce 50 percent transmission risk; discuss testing for children.
• Multidisciplinary care: Coordinate orthopaedics, nephrology and ophthalmology.

Knee Outcomes

Systemic Prognosis

• Skeletal features: Stable, non-progressive, function usually preserved.
• Nephropathy: Highly variable - many patients have only intermittent proteinuria, but a subset progress to end-stage renal failure; this is the principal determinant of long-term prognosis.
• Overall: Normal life expectancy in most, dominated by renal status.

Key Prognostic Points

• Iliac horns and nails are diagnostic but clinically inconsequential.
• Patellar surgery reliably helps pain more than instability.
• Renal surveillance is the single most important long-term action.

1. Surgery versus conservative management of the knee

• The largest series found surgically treated patients had lower KOOS/Kujala scores and the same rate of persistent instability as non-operated patients - yet reported good satisfaction. Whether and when to operate, and which procedure to choose, remains debated.

2. What "nail-patella syndrome" even means

• Discovery that some LMX1B homeodomain mutations cause isolated nephropathy without any nail, patellar or skeletal signs ("LMX1B-associated nephropathy") challenges the classic eponymous definition and blurs the boundary of the diagnosis.

3. Genotype-phenotype correlation

• There is no reliable correlation between LMX1B mutation and severity of renal or skeletal disease, so risk cannot be predicted from the genotype alone - mandating lifelong surveillance.

4. Role of patellectomy

• Historically used for end-stage patellofemoral arthritis, but complete patellar loss can itself cause anterior knee instability, so its role is increasingly limited.

Global epidemiology

• NPS is rare, around 1 in 50,000, with worldwide distribution and autosomal dominant inheritance; roughly half of cases may be new (de novo) mutations.
• The skeletal tetrad is highly penetrant (nails ~98 percent, patellar changes ~90 percent, iliac horns ~70 percent, elbow dysplasia ~70 percent); nephropathy affects a substantial minority and drives prognosis.

Side-by-side guidance

Registry and outcome notes

• No NPS-specific registry exists given the rarity; the strongest orthopaedic evidence is a single large questionnaire-based series and small surgical case series, so recommendations are necessarily low-level.

High- vs limited-resource practice

• Where available, MRI and LMX1B genetic testing refine the knee plan and confirm diagnosis, and multidisciplinary clinics coordinate renal/ophthalmic care.
• In limited-resource settings, the diagnosis can still be made on clinical examination plus a plain AP pelvis (iliac horns), and the priority is urine dipstick surveillance and blood pressure to catch treatable nephropathy early.

Other causes of patellar instability / absent patella:

• Isolated trochlear dysplasia / patellofemoral instability: No nails, iliac horns, or renal features.
• Small patella syndrome (ischiopubic-patellar): Patella hypoplasia with pelvic anomalies but no iliac horns or nail changes.
• Patella aplasia-hypoplasia (PTLAH): Isolated patellar maldevelopment without the full tetrad.

Key differentiators for NPS:

• Iliac horns on pelvis radiograph (pathognomonic).
• Triangular lunulae and dystrophic nails.
• Family history (autosomal dominant) and proteinuria.

Red flags:

• Proteinuria or hypertension → nephrology referral (prognosis driver).
• Visual symptoms → glaucoma assessment.
• Anterior knee instability with intact cruciates → consider absent patella.

Associated conditions:

• Open-angle glaucoma.
• LMX1B-associated isolated nephropathy in relatives.